FDA NDC Directory · JSON-LD · Markdown
NDC 50881-006 · HUMAN PRESCRIPTION DRUG · INJECTION
| Generic name | retifanlimab-dlwr |
|---|---|
| Labeler / Manufacturer | Incyte Corporation |
| Marketing category | Biologic License Application · App BLA761334 |
| Dosage form / route | INJECTION · INTRAVENOUS |
| Active ingredients | RETIFANLIMAB (25 mg/mL) |
| Marketing started | 20230322 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).